Biohaven Ltd. (BHVN)
11.21
-0.18
(-1.58%)
USD |
NYSE |
Feb 20, 14:16
Biohaven EPS Diluted (Quarterly) : -1.639 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Nektar Therapeutics | -1.875 |
| Protagonist Therapeutics, Inc. | -0.6169 |
| Dyne Therapeutics, Inc. | -0.7619 |
| Compass Therapeutics, Inc. | -0.0845 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -173.44M |
| Total Expenses (Quarterly) | 173.44M |
| Enterprise Value | 1.565B |
| Earnings Yield | -67.78% |
| Normalized Earnings Yield | -67.94 |